期刊文献+

心房颤动患者高敏C反应蛋白与血栓前状态标志物相关性分析 被引量:1

Correlation Analysis between Plasma High-Sensitivity C-Reactive Levels and Biomarks of Prethrombotic State in Patients with Atrial Fibrillation
下载PDF
导出
摘要 目的:观察心房颤动(简称房颤)患者血浆高敏C反应蛋白(hs-CRP)、血管性假血友病因子(v WF)、D-二聚体及纤维蛋白原(Fbg)的变化情况并分析其相关性。方法 :选取房颤组95例患者及窦性心律对照组55例患者,比较两组血浆hs-CRP、v WF、D-二聚体及Fbg水平。结果:房颤组hs-CRP、v WF、D-二聚体均高于对照组(P<0.05);Fbg水平在房颤组与对照组的差异无统计学意义(P>0.05)。在房颤组中,hs-CRP与血栓前状态相关指标v WF、Fbg及D-二聚体存在正相关(P<0.05)。结论:房颤患者存在血栓前状态,与炎症反应相关。 Objective :To analyze correlation between plasmahigh-sensitivity C-reactive(hs-CRP) levels, von Willebrand Factor(v WF), D-dimmer and fibrinogen(Fbg) in patients with atrial fibrillation(AF). Methods :95 AF patientsand 55 normal sinus rhythm patients were enrolled in this study. The levels of plasma v WF, D-dimmer, Fbg and hs-CRP were compared among the groups, respectively. Results : Compared to control group, plasma hs-CRP,v WF and D-dimmer were significantly increased in AF patients(P〈0.05). There was no statistic difference of Fbg between two groups(P〈0.05). In AF patients, plasma hs-CRP levels were correlated with v WF, D-dimmer and Fbg(P〈0.05). Conclusions :Prethrombotic state exists in patients with atrial fibrillation and is associated with inflammation.
出处 《岭南急诊医学杂志》 2016年第5期477-479,共3页 Lingnan Journal of Emergency Medicine
基金 广东省科技计划项目(2013B0218 00109)
关键词 心血管病学 心房颤动 血栓前状态 炎症反应 高敏C反应蛋白 cardiology atrial fibrillation prethrombotic state inflammation hs-CRP
  • 相关文献

参考文献1

二级参考文献8

  • 1Schnabel RB,Iarson MG,Yamamoto JF,et al.Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.Circulation,2010,121:200-207.
  • 2Boos C J,Anderson RA,Lip GY.Is atrial fibrillation an inflammatory disorder? Eur Heart J,2006,27:136-149.
  • 3Goldman ME,Pearce LA,Hart RG,et al.Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation:I.Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation[SPAF-Ⅲ] study).J Am Soc Echocardiogr,1999,12:1080-1087.
  • 4Matín F,Corral J,Roldán V,et al.Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.J Mol Cell Cardiol,2004,37:699-704.
  • 5Lip GY,Patel JV,Hughes E,et al.High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation:relationship to stroke risk factors,stroke risk stratification schema,and prognosis.Stroke,2007,38:1229-1237.
  • 6Adjusted-dose warfarin versus low-intensity,fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation:Stroke Prevention in Atrial Fibrillation Ⅲ randomised clinical trial.Lancet,1996,348:633-638.
  • 7Gage BF,van Walraven C,Pearce L,et al.Selecting patients with atrial fibrillation for anticoagulation:stroke risk stratification in patients taking aspirin.Circulation,2004,110:2287-2292.
  • 8Lip GY,Lane D,Van Walraven C,et al.Additive role of plasma yon Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.Stroke,2006,37:2294-2300.

共引文献10

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部